Navigation Links
ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter 2007 Financial Results
Date:3/4/2008

IRVINE, Calif., March 4 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will release fourth quarter 2007 financial results on March 6, 2008, after the U.S. markets close. ISTA will host a conference call, with a simultaneous webcast, to discuss these results and provide a commercial and pipeline update at 5:00 p.m. Eastern Time on March 6.

To access the live conference call, U.S. and Canadian participants may dial 866-831-6270; international participants may dial 617-213-8858. The access code for the live call is 99457780. To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 57762235. This conference call also will be webcast live and archived on ISTA's website until April 7, 2008, at http://www.istavision.com.

About ISTA

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
2. Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
3. MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results
4. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
5. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
6. VIA Pharmaceuticals to Present at Susquehanna and Rodman & Renshaw Conferences on March 4, 2008
7. Lotus Pharmaceuticals Raises $5 Million in Private Placement
8. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
9. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
10. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
11. RHEI Pharmaceuticals Licenses Attental From MethaPharma (Vemedia Group) for Distribution Throughout Asia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 The 2014 Warrior-Family ... Ronald Reagan Building and International Trade Center in ... Families and Civilian Communities,” will be held from ... 7:30 a.m.) and cohosted by the Military Officers ... Industrial Association (NDIA). USAA is the Executive Sponsor ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Aaron Marshall, Corporate ... The Hearing and Speech Agency for the 2014-2015 ... Of his appointment, Marshall states, "“Serving on the HASA ... others are living and helps me remember how much others ... of Law graduate, Aaron also has a B.S. in Finance ...
(Date:7/22/2014)... Steven Reinberg HealthDay Reporter ... treatments that break up blood clots deep in the veins ... risk. However, one results in a greater risk of bleeding ... of the other treatment, a new study finds. The ... thrombosis (DVT) -- is blood-thinning medications and compression stockings. The ...
(Date:7/22/2014)... July 22, 2014) The American Society of ... the University of California Los Angeles with the ... in iron homeostasis, including the discovery of the iron-regulatory ... metabolism. This award, named after the Nobel Prize Laureate ... pioneering research achievements in hematology that have represented a ...
(Date:7/22/2014)... using electric power morcellation, uterine cancers were present in ... procedure, according to a study published by JAMA ... which the uterus is fragmented into smaller pieces, may ... the commercial availability of electric power morcellators for 2 ... the time of electric power morcellation (in this study ...
Breaking Medicine News(10 mins):Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 2Health News:2014 Warrior-Family Symposium Focuses on Transitioning Forward 3Health News:New Board President for Baltimore-based Nonprofit 2Health News:Study Casts Doubt on Costly Treatment for Leg Clots 2Health News:Study Casts Doubt on Costly Treatment for Leg Clots 3Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 3Health News:Study examines presence of uterine cancers at the time of hysterectomy using morcellation 2
... A five year study undertaken by the King’s College, ... leading to premature death in many people//. This study ... ,According to this research, continued use of sedatives called ... people suffering from Alzheimer's and other types of dementia. ...
... The impact of exercise on body fat differs for boys and ... of Sports Medicine. ,Recommendations on exercise to curb the ... unisex approach, say the authors. ,The findings are based ... 10 at 12 schools in the Republic of Ireland. ...
... March 29 (DPA) A Serbian patient has survived more than ... the Belgrade daily Blic reported Thursday.// ,The gauze ... ago, a spokesman of the Sremska Kamenica cardiovascular institute, 70 ... ,It was found during surgery in mid-March. The latter ...
... died in Indonesia after apparently contracting the lethal H5N1 strain ... ,A preliminary test has revealed the presence of the ... West Sumatra and a 28-year-old woman from Jakarta. ... released. If they confirm the initial test results, Indonesia's death ...
... in blindness among children in a big way in the North ... ,As much as 51.6 per cent of the children in ... over a period of time only because of vitamin-related problems. Effective ... the poor of the North East, a study reveals. ,There is ...
... overweight men who are diagnosed with prostate cancer by biopsy ... a more aggressive// case of the disease than the biopsy ... Duke University Medical Center researcher. ,The finding suggests ... overweight men to receive inadequate or inappropriate treatment that is ...
Cached Medicine News:Health News:Alzheimer's Drugs Lead To Early Deaths 2Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 2Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 3
(Date:7/22/2014)... July 22, 2014  Nektar Therapeutics (Nasdaq: NKTR ... ended June 30, 2014 on Thursday, July 31, 2014, after ... president and chief executive officer, will host a conference call ... (ET)/2:00 p.m. Pacific Time (PT). The press ... can be accessed through a link that is posted on ...
(Date:7/22/2014)... NASHVILLE, Tenn. , July 22, 2014 ... will release second quarter 2014 financial results after the ... call and live Internet webcast will be held on ... to discuss the results. To participate in ... 253-237-1032 (for international callers).  A rebroadcast of the teleconference ...
(Date:7/22/2014)... Research and Markets has announced the addition ... Reagent, by Application - Global Forecast to 2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Biopharmaceuticals are pharmaceutical products isolated ... most important and widely used techniques for biopharmaceutical production. ... cell culture market in 2013. Growth in the biopharmaceutical ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3
... 3730xl DNA Analyzer reduces the time, cost, ... Higher optical sensitivity and advanced polymers enable ... less. , Multiple automation features decrease costly ... productivity without compromising your results. , Perform ...
This unique kit contains three pipettes conveniently packaged with useful accessoriesat an economical price....
... test is an immunochromatography based one ... for qualitative determination of Phencyclidine in ... of 25 ng/mL. This assay has ... of care location,and is for use ...
... test is an immunochromatography based one ... for qualitative determination of Methamphetamine in ... of 1000 ng/mL. This assay has ... of care,location and is for use ...
Medicine Products: